We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Low Profile Blade Facilitates Shave Biopsy

By HospiMedica International staff writers
Posted on 16 May 2013
A flexible, sterile blade is specifically designed for cutaneous surgery, making the process of skin biopsy safer for the patient.

The Personna DermaBlade is a sterile, disposable, very flexible, and extremely sharp device used for removal of skin protuberances, saucerization of flat lesions, and shave biopsy at any level of the dermis. More...
The blade also features Microcoat coating technology to provide sharp, smooth, precision cutting with less tissue trauma and scarring. Sure grip side teeth provide stability and control and prevent slipping in gloved hands, regardless of blade position. The Personna DermaBlade is a product of Personna (Verona, VA, USA).

“Once a user tries DermaBlade, they stay with DermaBlade and ask for it by name,” said Bob Senesac, director of marketing at Personna. “The simplicity of the product, its performance and the positive impact on patient results, sets it apart. While other products make similar claims, their products simply cannot match the DermaBlade.”

“The DermaBlade is a wonderful device that is much better than the usual surgical blades,” said Leonard Goldberg MD, FRCP, of Dermsurgery Associates (Houston, TX, USA). “I use it for the removal of lesions in the mid or upper dermis without having to remove the whole dermis with the lesion. I also use it for harvesting split thickness skin grafts which is an excellent way to repair small defects.”

Shave biopsy involves using a razor to shave only a small fragment of a protruding tumor, leaving the skin relatively flat after the procedure. Hemostasis is obtained using light electrocautery, Monsel's solution, or aluminum chloride. It is considered the ideal method of diagnosis for basal cell cancer, and can also be used to diagnose squamous cell carcinoma and melanoma in situ; however, the doctor's understanding of the growth of these last two cancers should be considered before one uses the shave method. The procedure is user skill dependent, as some surgeons can remove a small fragment of skin with minimal blemish using any one of the above tools, while others have great difficulty securing the devices.


Related Links:

Personna


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Pediatric Cast Saw
CSP-201 Quietcast
New
Portable Digital Floor Scale
DR400C
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The novel AI model boosts early detection and treatment of delirium (Photo courtesy of 123RF)

AI Model Boosts Early Delirium Detection for Improving Health Outcomes of Hospitalized Patients

Delirium, a sudden onset of severe confusion, poses serious life-threatening risks and affects up to one-third of patients in hospitals, often going unnoticed. Without intervention, it can lengthen hospital... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.